TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Anti-Obesity Drugs Market Size to Reach $35.52 Billion by 2032, Driven by Advancements in Weight Management Therapies and Rising Obesity Prevalence | SNS Insider

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Sns Insider
Anti-Obesity Drugs Market Size to Reach $35.52 Billion by 2032, Driven by Advancements in Weight Management Therapies and Rising Obesity Prevalence | SNS Insider

The global anti-obesity drugs market is projected to grow from $5.75 billion in 2024 to $35.52 billion by 2032, driven by rising obesity rates, advancements in GLP-1 therapies, and expanding digital prescription platforms.

Insights
NVDA   neutral

Mentioned briefly as a technology partner for AI Cloud Protect, with no significant performance details in the main article


NVO   positive

Leading pharmaceutical company in anti-obesity drug market with strong market position and innovative therapies like semaglutide